FCM
CRL icon

Frontier Capital Management’s Charles River Laboratories CRL Stock Holding History

Frontier Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
50,938
+2,876
+6% +$512K 0.11% 237
2026
Q1 		$8.29M Sell
48,062
-75,639
-61% -$14M 0.09% 250
2025
Q4 		$24.7M Buy
123,701
+73,426
+146% +$13.3M 0.26% 144
2025
Q3 		$7.87M Sell
50,275
-1,526
-3% -$242K 0.07% 262
2025
Q2 		$7.86M Sell
51,801
-19,271
-27% -$2.57M 0.07% 259
2025
Q1 		$10.7M Sell
71,072
-2,143
-3% -$359K 0.12% 211
2024
Q4 		$13.5M Sell
73,215
-133
-0.2% -$25.6K 0.13% 195
2024
Q3 		$14.4M Sell
73,348
-1,033
-1% -$215K 0.14% 193
2024
Q2 		$15.4M Buy
74,381
+6,255
+9% +$1.42M 0.15% 192
2024
Q1 		$18.5M Buy
68,126
+17,003
+33% +$4.06M 0.17% 170
2023
Q4 		$12.1M Buy
51,123
+3,711
+8% +$730K 0.12% 190
2023
Q3 		$9.29M Buy
47,412
+20,076
+73% +$4.12M 0.1% 197
2023
Q2 		$5.75M Sell
27,336
-279
-1% -$55.5K 0.06% 227
2023
Q1 		$5.57M Sell
27,615
-2,492
-8% -$565K 0.06% 224
2022
Q4 		$6.56M Buy
+30,107
New +$6.57M 0.07% 220
2014
Q2 		– Sell
-317
Closed -$19K – 346
2014
Q1 		$19K Sell
317
-891,784
-100% -$52M ﹤0.01% 337
2013
Q4 		$47.3M Buy
892,101
+43,521
+5% +$2.19M 0.35% 101
2013
Q3 		$39.3M Buy
848,580
+118,850
+16% +$5.45M 0.3% 114
2013
Q2 		$29.9M Buy
+729,730
New +$31.3M 0.25% 146

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Frontier Capital Management's CRL Position: Q2 2026 in Review

Frontier Capital Management increased its Charles River Laboratories (CRL) stake by 6% in Q2 2026, buying an estimated $512K and bringing the position to 50,938 shares worth $11.6M. The position accounts for 0.11% of the portfolio, ranked #237.

Frontier Capital Management first reported a position in CRL in Q2 2013 and has held it in 19 quarters since. The position peaked at $47.3M in Q4 2013. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Frontier Capital Management held 50,938 shares of Charles River Laboratories worth $11.6M as of Q2 2026.
  • Frontier Capital Management bought 2,876 Charles River Laboratories shares in Q2 2026, an estimated $512K.
  • Charles River Laboratories made up 0.11% of Frontier Capital Management's portfolio in Q2 2026, its #237 holding.
  • Frontier Capital Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 19 quarters since.
  • Frontier Capital Management's Charles River Laboratories position peaked at $47.3M in Q4 2013.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.